• VIP Club!
  • Podcast
  • Resources
  • About Us

This product is available.

"At 10 days in, my knee was painless and I was back at the gym working out like before the pain had started."

-Mike W., Mimi's Miracle Turmeric Customer

Mimi's Miracle Turmeric™

Free Gift

Mimi's Miracle Turmeric uses patented CurQLife technology to reduce pain and inflammation. Tests show that Mimi's Miracle Turmeric was 10 times more potent in the bloodstream, after 3 hours, than the top selling turmeric product in the US! Try Mimi's Miracle Turmeric today and experience the freedom of reduced pain, stiffness, and inflammation.

Live with less joint pain and increased mobility.

Clinically proven to reduce joint stiffness and swelling.

We formulated Mimi's Miracle Turmeric to be the highest quality turmeric supplement on the market, and it has clinical trials to back it up.

In a placebo-controlled study on patients with Osteoarthritis, Mimi's Miracle Turmeric was shown to reduce joint pain and swelling by up to 94.8%. On top of that, participants experienced increased mobility and reduced stiffness.

Don't let joint pain hold you back.

Turmeric is a famous anti-inflammatory used to treat inflammation pain, but most turmeric products hardly absorb into the body.

Mimi's Miracle Turmeric uses patented technology to provide unmatched levels of curcuminoids to the body. Research has shown that Mimi's Miracle Turmeric has 48-fold higher bioavailability levels than standard curcuminoids, and 10x higher bioavailability than the nations leading Turmeric supplement brand.

Turmeric in its most potent form, designed to to be the world's premier natural inflammation killer.

Containing the patented product CurQlife with Boswellia, Mimi's Miracle Turmeric is a novel composition of Curcuma longa extract and BNRE at 1:1 ratio. These two proven ingredients are combined together to enhance potency and provide broad spectrum efficacy while being safe. Mimi's Miracle Turmeric alleviates inflammation and oxidative stress by inhibiting the expression of pro-inflammatory cytokines, and inhibiting the activity of COX-2 and iNOS. It also suppress the activity and expression of COX-2, LOX, iNOS, MMP-9, and FPTase. This means that the ingredients in our star ingredient, CurQLife, are acting to stop certain signals the body gives when it's in pain. This is reflected in a reduction of inflammation. Mimi's Miracle Turmeric with BNRE technology is the next stage in natural anti-inflammation technology. BNRE (Boswellia Non-Acidic Resin Extract) technology is a patented proprietary extract derived from Boswellia Serrata gum resin. BNRE has been found to have remarkable anti-inflammatory and anti-oxidative activities. BNRE has been found to inhibit the production of pro-inflammatory cytokines (TNF-α) and interleukin-1beta (IL1β). This helps to produce a healthy inflammation response naturally without any side effects.

Take one (1) softgel in the morning and one (1) in the evening, or as recommended by a healthcare practitioner.

Store at room temperature. Does not require refrigeration.

Advanced Directions
Keeping this product in your system 24/7 helps it work optimally, hence the reason for taking one in the morning and one at night. For most people, this product will not upset an empty stomach, so taking one at 6 AM before breakfast and one at 6 PM is ideal, 12 hours apart. 7 and 7 would work as well, you get the idea. 

This product is HIGHLY CONCENTRATED, so taking additional pills is not necessary. Just take the 2 per day as recommended.


See white paper info below for more detailed description of these studies and their findings.

Clinical Study 1: Patients experienced significant pain relief, a reduction in joint stiffness, and an increase in mobility in comparison to the control placebo. (Study done on patients with Osteoarthritis)

Clinical Study 2: Bioavailability study showed a 48-fold higher bioavailability than standard curcuminoids and 10x higher bioavailability than the market leading brand.

Clinical Study 3: Primary ingredient CurQLife® patented technology allows for 80% Curcuminoid release at 30 minutes and 95% dissolution within 1 hour. Most other turmeric brands have such a low percentage of absorption that the turmeric is disposed without use.

Clinical Study 4: In a 32 week randomized, placebo controlled study the active group had significantly less pain at weeks 16 and week 32 than the placebo group. 

Clinical Study 5: Conducted on patients with Osteoarthrisis. Following 2 weeks of therapy, patients showed significant improvement in joint swelling, morning stiffness, and walking time.


In the United States, 23% of all adults, or over 54 million people, have arthritis. Almost 300,000 babies and children have arthritis or a rheumatic condition (1 in 250 children). Arthritis is a leading cause of disability. The annual direct medical costs are at least 81 billion.(10) 

The term arthritis refers to more than 100 diseases and conditions affecting the joints.(10) The most common type of arthritis is osteoarthritis. Other forms of arthritis are gout, lupus, and Osteoarthrisis. 

Symptoms of arthritis are pain, aching, stiffness, and swelling in or around the joints. Arthritis can affect multiple organs and cause widespread symptoms. Arthritis commonly occurs with other chronic diseases. About half of US adults with heart disease or diabetes and one-third of people who are obese also have arthritis. Having arthritis and other chronic conditions can reduce quality of life and make disease management harder. 

Sixty percent of US adults with arthritis are of working age (18-64 years).(9)  Arthritis can limit the type of work these men and women are able to do or keep them from working at all. In fact, 8 million working-age adults report that their ability to work is limited because of their arthritis.(9) 

The most common limitations that adults with arthritis report are difficulty climbing a flight of stairs or walking the equivalent of three city blocks. This means that adults with arthritis could have trouble walking from a parking deck or subway stop to their worksite. 

The impact of arthritis on the productivity of US businesses will continue to grow as the percentage of people with this condition increases in the coming decades. People with osteoarthritis and Osteoarthrisis (just two kinds of arthritis) miss a combined 172 million workdays every year. By 2040, more than 78 million people (26% of the projected adult population) will have arthritis.(9) 

Arthritis is the nation’s No. 1 cause of disability.(See figure 1) 

Economic Impact 

Arthritis and other non-traumatic joint disorders are among the five most costly conditions among adults 18 and older. 

Every year, people with arthritis and other rheumatic conditions give up potential income (called “lost wages”) due to injury or illness. Arthritis and related conditions account for more than $156 billion annually in lost wages and medical expenses(9). More than 100 million outpatient visits, an estimated 6.7 million hospitalizations.(10) In 2011 there were 757,000 knee replacements and 512,000 hip replacements.


(Figure 1) 

Figure 1- Arthritis/rheumatism are among the top causes of disability among US adults.

Turmeric / Curcumin 
Curcumin is the main component of the spice turmeric. It has been used in Eastern medicine for many, many years. Curcumin has been shown to be beneficial for everything from Arthritis and Alzheimer's to Crohn's disease. We are focusing on its anti-inflammatory properties. 

Curcumin works like a Cox-2 inhibitor to reduce inflammation in the body without many of the negative side effects of prescription drugs. By lowering inflammation, you can have reduced pain and greater mobility which can lead to many health and life improvements. Increased mobility is a building block of health as it starts a cascade of positive health benefits. 

Turmeric/Curcumin has been found to help lower inflammation and support joints once it gets into the bloodstream. One of the drawbacks of increasing turmeric to get more curcumin in your diet is that it's very hard for the body to absorb. Unfortunately, most leading curcumin products do not reach the bloodstream and do not pass the metabolization process. 

CurQLife® is a patented turmeric formulation with extensive clinical trials to support it, showing a 48-fold higher bioavailability than standard curcuminoids and 10x higher bioavailability than the market leading brand. * CurQLife® patent technology allows for 80% Curcuminoid release at 30 minutes and 95% dissolution within 1 hour. Most other turmeric brands have such a low percentage of absorption that the turmeric is disposed without use. CurQLife® has been proven to enter the bloodstream and remain for 24 hours at the recommended dosage level. Further, CurQLife® has the highest level of free curcumin entering the bloodstream than any other brand on the market. Why does this matter? If free Curcumin is not entering the bloodstream, the body will not utilize the positive benefits of turmeric. 

(See figure 2) 

Figure 2- Tests show CurQLife at 48x higher bioavailability than standard curcuminoids.

HLB Technology
While the natural chemicals called Curcumonoids from Turmeric have proven to be beneficial to human health, they are poorly absorbed by the body and quickly eliminated. The makers of CurQLife have created a technology to improve the amount to Curcumonoids in the body.

The small intestine inner cell wall, where most food and vitamins are absorbed, has to ability to reject many chemicals by tagging them for quick removal.

The makers of CurQLife have created a cell like structure around the Curcumonoids. Imagine a hollow ball surrounding the Curcumonoids as if it were in its own "Cell" called a Micelle (pronounced "My- Cell").

The makers of CurQLife have named this HLB Technology. Because HLB technology has created a cell like structure, the CurQLife Micelle has the ability to “walk” the inner Curcumonoids past the small intestine inner cell wall. Since this barrier is now by-passed by the CurQLife Micelle, the inner Curcumonoids are not tagged by the small intestine inner cell wall for removal.

This allows the Curcumonoids to now move on to the blood stream and benefit the entire body. Simply consuming pure Curcumonoids, without HLB Technology, only results in almost all of it being excreted from the intestinal track. 


Dissolution Study 
In order to predict the bioavailability of CurQlife in comparison with unformulated Curcuminoids, a dissolution study was carried out. A dissolution study is a standard method for measuring the rate of drug release from dosage form. 

The preliminary dissolution study results reflecting stomach and intestine environment respectively, (at a ph of 1.2 and 6.8) confirms that CurQlife possesses far superior dissolution compared to unformulated Curcuminoids Hence, based on the dissolution study results, CurQlife is expected to have much better bioavailability and pharmacokinetic properties than unformulated Curcuminoids.

Figure 3- Testing shows CurQLife has far superior dissolution than standard competitors.

Pharmacokinetics (PK) is a fundamental scientific discipline that underpins applied therapeutics. Molecules with poor PK are reported to be poorly absorbed into the biological system and hence are therapeutically inefficient. This study was conducted to evaluate the bioavailability of orally administered CurQlife and unformulated curcuminoids 

CurQlife is clinically proven for its enhanced oral bioavailability in a comparative human bioavailability study. Hence the product presents a competitive advantage in terms of bioavailability and thereby its application in Joint health. 

CurQLife® has shown superior bioavailability when compared to other leading brands and standard curcuminoids. Its patented emulsification process enables the powerful curcuminoids to enter the bloodstream without being metabolized or wasted. 

Research shows a 48 fold increase over standard curcuminoid powder, and as much as 10 times higher bioavailability versus leading market competitors. The body’s ability to use CurQlife once it is in the circulatory system, leads to better efficacy.(3) 

Figure 4- CurQLife shown to have much higher curcumin concentration over time than other curcuminoids.

Clinical Studies

 A 60 day clinical study was carried out with males and females from the age of 40-75 with Osteoarthritis symptoms in their knees. Subjects who met the inclusion and exclusion criteria were randomized into the study in a 1:1 ratio in CurQlife L (N=20) and Placebo group (N=20). The study consisted of six visits including screening visit, visit 1 (baseline), visit 2, visit 3, visit 4, and visit 5. Subjects were requested to take one capsule of CurQlife L or placebo twice daily after food. The following charts display the results from the study.2 (See figure 5) 

Figure 5- Study participants taking CurQLife experienced a significant drop in joint pain and stiffness compared to the placebo.


The conclusion of this study was overwhelmingly supportive of the efficacy of CurQLife®. Patients experienced significant pain relief, a reduction in joint stiffness, and an increase in mobility, in comparison to the control placebo. Furthermore, zero patients had any adverse reactions. CurQLife® was shown to be effective against alleviating symptoms of knee osteoarthritis. 

Additional Research Study I
Madhu. K et al 2013, demonstrated the efficacy of curcumin formulation in a randomized, single blind, placebo-controlled trial in 120 patients with primary knee Osteoarthritis.1 The study found that posttreatment scores following administration of curcumin formulation using VAS & WOMAC, at each clinical visit showed significant decrease (p<0.05) compared to placebo. Curcumin treated group showed a significant (p<0.01) decrease in use of rescue medication, along with clinical and subjective improvement compared to placebo. The tolerability and acceptability profile of curcumin was better during the trial period.(1) 

Study II 
A pilot clinical study was performed by Binu Chandran et al 2012, to evaluate the safety and effectiveness of curcumin alone, and in combination with diclofenac sodium in patients with active rheumatoid arthritis (RA). 2 The study found that the curcumin group showed the highest percentage of improvement in overall DAS and ACR scores (ACR 20, 50 and 70) and these scores were significantly better than the patients in the diclofenac sodium group.2 More importantly, curcumin treatment was found to be safe and did not relate with any adverse events. 

Study III 
Long-term efficacy and safety of a curcumin formulation were investigated in an eight month study involving100 Osteoarthritis patients(OA).3 The study found that, all subjective and objective parameters were improved in the treatment group over the control group (p<0.05). The curcuminoid group had improved scores for joint pain, stiffness, and physical function.3 

Study IV 
Kuptniratsaikul et al 2009, determined the efficacy and safety of Curcuma extracts in pain reduction and functional improvement in patients with knee osteoarthritis.4 The mean scores of outcomes, pain on walking, pain on stairs, time spent 100 m. walk (sec), time spent up & down stairs (sec) at week 0, 2, 4, and 6 were significantly improved when compared with the baseline values in both groups. The study found that Curcuma extract was efficacious and safe for the treatment of knee OA similarly to ibuprofen.(4) 

(See figure 7) 

Figure 7- Participants with knee osteoarthritis experienced less pain walking and climbing stairs after taking CurQLife.


Study V 
Arvind Chopra et al 2004, evaluated the efficacy and safety of curcumin Ayurvedic formulation in 90 patients with symptomatic osteoarthritis (OA) of the knees in a 32-week randomized, placebo-controlled clinical study.5 Compared with placebo, the mean reduction in pain VAS at week 16 (active =2.7, placebo = 1.3) and week 32 (active = 2.8, placebo =1.8) in the active group was significantly better (P<0.05, analysis of variance ANOVA). Similarly, the improvement in the WOMAC scores at week 16 and week 32 were also significantly superior (P<0.01, ANOVA) in the active group.(5) 

(See figures 8 and 9) 

Figures 8/9- The mean change in modified WOMAC and pain visual analog scale at efficacy week endpoints by each treatment group.


Figure 8 and 9: The mean change in modified WOMAC and pain visual analog scale at efficacy week endpoints by each treatment group. 

Study VI 
Kulkarni RR et al 1991, demonstrated the efficacy of turmeric extract (50 mg/capsule) in combination with other ingredients in a randomized, double-blind, placebo controlled, cross-over study in 42 patients with osteoarthritis. Clinical efficacy was evaluated every fortnight on the basis of severity of pain, morning stiffness, Ritchie articular index, joint score, disability score and grip strength. Other parameters like erythrocyte sedimentation rate and radiological examination were carried out on a monthly basis. 6 Treatment with the turmeric extract in the formulation produced a significant drop in severity of pain (P<0.001)and disability score (P<0.05).(6) (Figures 8 and 9) 

Study VII 
Satoskar RR et al 1986, investigated the postoperative inflammation, the anti-inflammatory activity of curcumin (diferuloylmethane), in comparison with phenylbutazone and placebo.7 The study found that a dose of 400 mg of curcumin, three times per day, can reduce postoperative inflammation as effectively as the NSAID phenylbutazone.(7) 

Study VIII 
Deodhar et al 1980, performed a double-blind clinical trial in which curcumin 1200 mg/day was compared with phenylbutazone 300 mg/day in 18 patients with Rheumatoid arthritis.8 Following two weeks of curcumin therapy, patients showed significant (p<0.05) improvement in joint swelling, morning stiffness and walking time.(8) 

CurQlife is the premier ingredient for natural anti-inflammation for the entire body. CurQlife is a patented, clinically proven, highly bioavailable formulation containing Curcuminoids (95% Curcuma longa extract). This novel formulation delivers higher amounts of free curcumin to the blood, and other target organs, providing optimal health benefits. 

Developed by world famous Laila Nutraceuticals, CurQLife® is patented and specifically designed to have the highest market bioavailability. CurQLife® gets into the bloodstream within 30 minutes of ingestion, providing a sustained inflammation response for the entire day (at the recommended dosage). Further, clinical trials support CurQLife® as helping support healthy joints and supporting joint comfort. 

Clinical results have proven that CurQlife is effective in the management of osteoarthritis, and many other joint related pain areas. CurQlife has shown to have better absorption, stability, and protection of curcumin metabolism through HLB technology. CurQlife has also shown to have clinical relevance in multiple studies, strengthening the case for long duration and larger studies. CurQlife is a promising candidate for the long-term management of osteoarthritis.



1) Madhu. K et al Inflammopharmacol 2013; 21:129–136 

2) BinuChandranetal2012;Phytother.Res 

3) Belcaro Get al Altern Med Rev. 2010 Dec 15(4):337-44) 

4) Vilai Kuptniratsaikul et al The Journal of Alternative and Complementary Medicine 2009; Vol 15, Number 1 

5) ArvindChopraetalJCR:JournalofClinicalRheumatology2004;Volume10, Number 5 

6) Kulkarni RR et al Ethnopharmacol 1991; 33: 91-95

7) Satoskar RR et al Int J Clin Pharmacol Ther Toxicol 1986 Dec; 24(12):651-4 

8)  DeodharSDetalIndianJMedRes1980;71:632-634 

9)  Barbour KE, Helmick CG, Boring MA, Brady TJ. Vital signs: prevalence of doctor- diagnosed arthritis and arthritis-attributable activity limitation --- United States, 2013—2015. Morb Mortal Wkly Rep. 2017 March 7. 

10) Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis & Rheumatology. 2016 Mar 25. 

Q. Does it work for osteoarthritis in a back, lower and upper, shoulders, and neck? 
A. Mimi's turmeric contains an active ingredient called curcumin that helps lower inflammation and support joints once it gets into the bloodstream. One study of males and females between the ages of 40-75 with osteoarthritis symptoms in their knees showed significant pain relief, reduction in joint stiffness, and an increase in mobility after just 30 days, in addition, no patients reported any adverse reactions. 

Q. What is the shelf life?
A. The shelf life is 2 years. Keep it in a cool, dry place, away from sunlight. :)

Q. Where do you manufacture your products from? 
A. We are the formulators of all the Dirobi brand products and own all of the formulations. We then have them manufactured by contract manufacturers, one of which is local to us right here in Utah, and another is in southern California. Both are GMP certified facilities and manufacture our products to extremely high standards.

We have been manufacturing products since 2009, and have used various contract
manufacturers over the years. The ones we have now are the very best we have
ever used, and we keep their info as a trade secret, mostly to protect our brands
from competitors. 


Live with less joint pain and increased mobility

Customer Reviews

Based on 10 reviews
Stephanie McCurley
Mimi’s Miracle Turmeric

I purchased this item for my husband with chronic back pain and he reports that his pain has lessened. I will be reordering.

John Landreth
Pain Mitigation

Purchased product for wife's hip issues. Her mobility increased and her pain level decreased significantly after 3 weeks.

Best stuff ever!!

Bought for my mom with bad knees and helped her so much with reducing inflammation!

Linda Tucker
Better At Bedtime

I feel much better at bedtime because of this turmeric. I feel like it’s a high quality product. Very effective.

Nathan Sauvola

Very good